Vertex Pharmaceuticals Incorpor vs Johnson & Johnson — Stock Comparison
Q·Score Breakdown
8.4
Buy
Overall
7.1
Buy
Quality
Health
Growth
Valuation
Sentiment
VRTX
High-quality business with 23% return on equity and 33% profit margins.
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
BUY
Target $548.39 (+28.0%)
28 analysts
BUY
Target $252.42 (+10.1%)
24 analysts
Fundamentals
VRTX
JNJ
28.0×
Trailing P/E
26.5×
19.7×
Forward P/E
18.0×
32.9%
Profit Margin
21.8%
53.7%
Gross Margin
68.0%
22.5%
ROE
26.4%
9.5%
Revenue Growth
9.9%
32.9%
Earnings Growth
-52.9%
0.37
Beta
0.33
—
Price / Book
—
$109.0B
Market Cap
$552.0B
$363 – $509
52-Week Range
$146 – $252
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.